Article -> Article Details

Market Analysis

Various factors are adding to the global veterinary clostridium vaccine market share. The different veterinary clostridium vaccine market drivers, as per the new MRFR report, include rising consumption of products that are animal-derived, technological advances, increasing prevalence if clostridium family diseases, growing awareness about zoonotic diseases, and rise in disposable income. On the other hand, the rising consumption of milk and meat are impacting the human vaccines market.

On the contrary, strict regulations, high treatment costs, and certain side effects are factors that may limit the global animal clostridium vaccine market growth over the forecast period.

The global veterinary clostridium vaccine market was valued USD 461.7 million in 2017 and is predicted to grow at a 4.5% CAGR between 2018- 2023, reveals the new Market Research Future (MRFR) report. Clostridium bacteria are anaerobic in nature. They are mostly found in the gut of animals and humans, and in soil. Vaccination plays a pivotal part in protecting animals against this disease. Generally, these vaccines are used for animals like poultry, caprine, swine, ovine, bovine, and others. Such vaccines come in different varieties, including combinations and single vaccines. The combination vaccines comprise toxoids, bacterins, or a mixture of toxoids and bacterins.

Regional Analysis

The veterinary clostridium vaccine market in Europe is predicted to possess the second-largest share over the forecast period for the growing awareness about various veterinary clostridium vaccine products, growing awareness about zoonotic diseases, and increasing demand for livestock products. The UK and Germany are the key contributors in the region.

The veterinary clostridium vaccine market in the APAC region is predicted to grow at a fast pace over the forecast period for increased government initiatives, growing population in India China that is boosting the demand for meat products, increasing incidence of clostridial diseases, rise in disposable income, and growing awareness regarding clostridium vaccine products.

The veterinary clostridium vaccine market in the MEA is predicted to have the smallest share over the forecast period.

Key Players

Eminent players profiled in the global veterinary clostridium vaccine market report include Bayer AG (Germany), Elanco Animal Health (US), Zoetis (US), Valneva SE (France), Virbac (Australia), Colorado Serum Company (US), Boehringer Ingelheim International GmbH (Germany), Ceva Santé Animale (France), and Merck Co., Inc. (US). Key players have incorporated strategies such as contracts, geographic expansions, mergers and acquisitions, product launches, and strategic alliances, among others, to create a niche in the market and also cater to customers growing needs.

Geographically, the Americas is expected to dominate the global veterinary clostridium vaccine market owing to the presence of well-established players, increased awareness pertaining to zoonotic diseases, rising incidence rate of clostridium family diseases, increased awareness relating animal-derived products, and increase in disposable income. Europe is expected to hold the second largest position in the global veterinary clostridium vaccine market. Asia-Pacific is expected to be the fastest growing market owing to the increasing awareness about veterinary clostridium vaccine products and increase in disposable income. Furthermore, the Middle East and Africa region is expected to account for the least market share in the global veterinary clostridium vaccine market.